Abstract

Heat shock protein 27 (HSP27) is a member of the small molecular weight HSP family. Upon treatment with transforming growth factor β1 (TGF-β1), we observed upregulation of HSP27 along with that of α-smooth muscle actin (α-SMA), a marker of myofibroblast differentiation, in cultured human and mouse lung fibroblasts. Furthermore, by using siRNA knockdown, we demonstrated that HSP27 was involved in cell survival and upregulation of fibronectin, osteopontin (OPN) and type 1 collagen, all functional markers of myofibroblast differentiation, in TGF-β1-treated MRC-5 cells. In lung tissues of bleomycin-treated mice, HSP27 was strongly upregulated and substantially co-localized with α-SMA, OPN and type I collagen but not with proSP-C (a marker of type II alveolar epithelial cells), E-cadherin (a marker of epithelial cells) or F4/80 (a marker of macrophages). A similar co-localization of HSP27 and α-SMA was observed in lung tissues of patients with idiopathic pulmonary fibrosis. Furthermore, airway delivery of HSP27 siRNA effectively suppressed bleomycin-induced pulmonary fibrosis in mice. Collectively, our findings indicate that HSP27 is critically involved in myofibroblast differentiation of lung fibroblasts and may be a promising therapeutic target for lung fibrotic diseases.

Highlights

  • Fibrosis is the end stage of persistent tissue damage and chronic inflammatory reactions

  • We have further shown that Heat shock protein 27 (HSP27) is strongly upregulated and su bstantially colocalized with the myofibroblast markers in lung tissues from bleomycin-treated mice and from patients with idiopathic pulmonary fibrosis (IPF)

  • Myofibroblasts play pivotal roles in tissue repair and fibrosis, and Transforming growth factor β1 (TGF-β1) is the major inducer of myofibroblast differentiation from various cell sources including fibroblasts [3, 5]

Read more

Summary

Introduction

Fibrosis is the end stage of persistent tissue damage and chronic inflammatory reactions. It is characterized by the excessive accumulation of extracellular matrix (ECM) and disruption of normal tissue architecture [1, 2]. Myofibroblasts are the major effector cells in tissue repair and fibrosis through their copious production of ECM proteins [3, 4]. Role of HSP27 in Myofibroblast Differentiation (α-SMA) [3, 4], which contributes to enhanced motility and contractibility. Transforming growth factor β1 (TGF-β1), which plays a key role in tissue repair and fibrosis, is a potent inducer of myofibroblast differentiation [3, 5]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.